AP NEWS

Europe Head & Neck Cancer Market and Competitive Landscape - 2018 - ResearchAndMarkets.com

December 5, 2018

DUBLIN--(BUSINESS WIRE)--Dec 5, 2018--The “Europe Head & Neck Cancer Market and Competitive Landscape - 2018” report has been added to ResearchAndMarkets.com’s offering.

Europe Head & Neck Cancer Market and Competitive Landscape - 2018, provides comprehensive insights into Head & Neck Cancer pipeline, epidemiology, market valuations, product sales, market forecast, product forecasts, and market shares. This study accurately estimates and forecast Head & Neck Cancer market size and drug sales. This research also provides insights into Head & Neck Cancer epidemiology and late stage pipeline.

Research Scope

Head & Neck Cancer pipeline: Find out the drugs in clinical trials for Head & Neck Cancer by stages, phase 3 clinical trials, phase 2 clinical trials, and phase 1 clinical trials, by pharmacological class, by companyHead & Neck Cancer epidemiology: Find out the prevalence of Head & Neck Cancer by countries - Europe, Germany, France, Italy, Spain, UK; prevalence forecast to 2023Head & Neck Cancer products: Identify key products marketed and prescribed for Head & Neck Cancer by brand name, by molecule, by company, by branded / generic, by countries - Europe, Germany, France, Italy, Spain, UKHead & Neck Cancer market size: Find out the market size for Head & Neck Cancer drugs by countries - Europe, Germany, France, Italy, Spain, UK; Find out how the market advanced from 2014Head & Neck Cancer drug sales: Find out the sales of Head & Neck Cancer drugs by countries - Europe, Germany, France, Italy, Spain, UKHead & Neck Cancer drugs sales forecast: Sales forecast for Head & Neck Cancer drugs to 2023 by countries - Europe, Germany, France, Italy, Spain, UKHead & Neck Cancer market share analysis: Find out the market shares of Head & Neck Cancer drugs and outlook by countries - Europe, Germany, France, Italy, Spain, UK

For more information about this report visit https://www.researchandmarkets.com/research/4qlxwt/europe_head_and?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20181205005327/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Oncology Drugs

KEYWORD: EUROPE

INDUSTRY KEYWORD: HEALTH ONCOLOGY PHARMACEUTICAL

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 12/05/2018 06:15 AM/DISC: 12/05/2018 06:15 AM

http://www.businesswire.com/news/home/20181205005327/en

AP RADIO
Update hourly